CAG REPEAT NUMBER IN THE ANDROGEN RECEPTOR
GENE AND PROSTATE CANCER
Madjunkova S, Eftimov A, Georgiev V, Petrovski D, Dimovski AJ, Plaseska-
Karanfi lska D,
*Corresponding Author: Professor Dr. Dijana Plaseska-Karanfi lska, Macedonian Academy of Sciences
and Arts, Research Center for Genetic Engineering and Biotechnology “Georgi D. Efremov”, Av. Krste
Misirkov 2, POB 428, 1000 Skopje, Republic of Macedonia; Tel.: +389-2-3235-410; Fax: +389-2-3115-
434; E-mail: dijana@manu.edu.mk
page: 31
|
|
REFERENCES
1. Crawford ED. Epidemiology of prostate cancer.
Urology. 2003; 62(6): 3-12.
2. Gronberg H. Prostate cancer epidemiology. Lancet.
2003; 361(9360): 859-864.
3. Haas GP, Sakr WA. Epidemiology of prostate cancer.
CA Cancer J Clin. 1997; 47(5): 273-287.
4. Scosyrev E, Messing EM, Mohile S, Golijanin D,
Wu G. Prostate cancer in the elderly: frequency of
advanced disease at presentation and disease-specific
mortality. Cancer. 2011; doi: 10.1002/cncr.26392.
[Epub ahead of print].
5. Nelson KA, Witte JS. Androgen receptor CAG
repeats and prostate cancer. Am J Epidemiol. 2002;
155(10): 883-890.
6. Mittal RD, Mishra D, Mandhani AK. Role of an an
drogen receptor gene polymorphism in development
of hormone refractory prostate cancer in Indian population.
Asian Pac J Cancer Prev. 2007; 8(2): 275-278.
7. Cotter MP, Gern RW, Ho GY, Chang RY, Burk RD.
Role of family history and ethnicity on the mode and
age of prostate cancer presentation. Prostate. 2002;
50(4): 216-221.
8. Du XL, Fang S, Coker AL, Sanderson M, Aragaki
C, Cormier JN, Xing Y, Gor BJ, Chan W. Racial disparity
and socioeconomic status in association with
survival in older men with local/regional stage prostate
carcinoma: fi ndings from a large communitybased
cohort. Cancer. 2006; 106(6): 1276-1285.
9. Schaid DJ. The complex genetic epidemiology of
prostate cancer. Hum Mol Genet. 2004; 13(Spec No
1): R103-121.
10. Feldman BJ, Feldman D. The development of andro
gen-independent prostate cancer. Nat Rev Cancer.
2001; 1(1): 34-45.
11. Lu S, Tsai SY, Tsai MJ. Regulation of androgendependent
prostatic cancer cell growth: androgen
regulation of CDK2, CDK4, and CKI p16 genes.
Cancer Res. 1997; 57(20): 4511-4516.
12. Montgomery JS, Price DK, Figg WD. The androgen
receptor gene and its infl uence on the development
and progression of prostate cancer. J Pathol. 2001;
195(2): 138-146.
13. Edwards A, Hammond HA, Jin L, Caskey CT,
Chakraborty R. Genetic variation at fi ve trimeric and
tetrameric tandem repeat loci in four human population
groups. Genomics. 1992; 12(2): 241-253.
14. Giovannucci E, Stampfer MJ, Krithivas K, Brown
M, Dahl D, Brufsky A, Talcott J, Hennekens CH,
Kantoff PW. The CAG repeat within the androgen
receptor gene and its relationship to prostate cancer.
Proc Natl Acad Sci USA. 1997; 94(7): 3320-3323.
15. Chamberlain NL, Driver ED, Miesfeld RL. The
length and location of CAG trinucleotide repeats
in the androgen receptor N-terminal domain affect
transactivation function. Nucleic Acids Res .1994;
22(15): 3181-3186.
16. Hardy DO, Scher HI, Bogenreider T, Sabbatini P,
Zhang ZF, Nanus DM, Catterall JF. Androgen receptor
CAG repeat lengths in prostate cancer: correlation
with age of onset. J Clin Endocrinol Metab.
1996; 81(12): 4400-4405.
17. Stanford JL, Just JJ, Gibbs M, Wicklund KG, Neal
CL, Blumenstein BA, Ostrander EA. Polymorphic
repeats in the androgen receptor gene: molecular
markers of prostate cancer risk. Cancer Res. 1997;
57(6): 1194-1198.
18. Irvine RA, Yu MC, Ross RK, Coetzee GA. The CAG
and GGC microsatellites of the androgen receptor
gene are in linkage disequilibrium in men with prostate
cancer. Cancer Res. 1995; 55(9): 1937-1940.
19. Zeegers MP, Kiemeney LA, Nieder AM, Ostrer H.
How strong is the association between CAG and
GGN repeat length polymorphisms in the androgen receptor
gene and prostate cancer risk? Cancer Epidemiol
Biomarkers Prev. 2004; 13(11): 1765-1771.
20. Price DK, Chau CH, Till C, Goodman PJ, Baum CE,
Ockers SB, English BC, Minasian L, Parnes HL,
Hsing AW, Reichardt JK, Hoque A, Tangen CM,
Kristal AR, Thompson IM, Figg WD. Androgen
receptor CAG repeat length and association with
prostate cancer risk: results from the prostate cancer
prevention trial. J Urol. 2010; 184(6): 2297-2302.
21. Lindstrom S, Ma J, Altshuler D, Giovannucci E,
Riboli E, Albanes D, Allen NE, Berndt SI, Boeing H, Bueno-de-Mesquita HB, Chanock SJ, Dunning AM,
Feigelson HS, Gaziano JM, Haiman CA, Hayes RB,
Henderson BE, Hunter DJ, Kaaks R, Kolonel LN,
Le Marchand L, Martinez C, Overvad K, Siddiq
A, Stampfer M, Stattin P, Stram DO, Thun MJ,
Trichopoulos D, Tumino R, Virtamo J, Weinstein SJ,
Yeager M, Kraft P, Freedman ML. A large study of
androgen receptor germline variants and their relation
to sex hormone levels and prostate cancer risk.
Results from the National Cancer Institute Breast
and Prostate Cancer Cohort Consortium. J Clin
Endocrinol Metab. 2010; 95(9): E121-E127.
22. Mishra D, Thangaraj K, Mandhani A, Kumar A,
Mittal R. Is reduced CAG repeat length in androgen
receptor gene associated with risk of prostate cancer
in Indian population? Clin Genet. 2005; 68(1): 55-60.
23. Hakimi JM, Schoenberg MP, Rondinelli RH,
Piantadosi S, Barrack ER. Androgen receptor variants
with short glutamine or glycine repeats may
identify unique subpopulations of men with prostate
cancer. Clin Cancer Res. 1997; 3(9): 1599-1608.
24. Hsing AW, Gao YT, Wu G, Wang X, Deng J, Chen
YL, Sesterhenn IA, Mostofi FK, Benichou J, Chang
C. Polymorphic CAG and GGN repeat lengths in
the androgen receptor gene and prostate cancer risk:
a population-based case-control study in China.
Cancer Res. 2000; 60(18): 5111-5116.
25. Akinloye O, Gromoll J, Simoni M. Variation in
CAG and GGN repeat lengths and CAG/GGN haplotype
in androgen receptor gene polymorphism and
prostate carcinoma in Nigerians. Br J Biomed Sci.
2011; 68(3): 138-142.
26. Plaseski T, Noveski P, Dimitrovski C, Kocevska
B, Efremov GD, Plaseska-Karanfi lska D. CAG
Repeat number in androgen receptor gene and male
infertility. BJMG. 2007; 10(1): 19-24.
27. Coetzee GA, Ross RK. Re: prostate cancer and the
androgen receptor. J Natl Cancer Inst. 1994; 86(11):
872-873.
28. Ding D, Xu L, Menon M, Reddy GP, Barrack ER.
Effect of a short CAG (glutamine) repeat on human
androgen receptor function. Prostate. 2004; 58(1):
23-32.
29. Gu M, Dong X, Zhang X, Niu W. The CAG repeat
polymorphism of androgen receptor gene and prostate
cancer: a meta-analysis. Mol Biol Rep. 2011;
39(3): 2615-2624.
30. Binnie MC, Alexander FE, Heald C, Habib FK.
Polymorphic forms of prostate specifi c antigen and
their interaction with androgen receptor trinucleotide
repeats in prostate cancer. Prostate. 2005; 63(4):
309-315.
31. Correa-Cerro L, Wohr G, Haussler J, Berthon P,
Drelon E, Mangin P, Fournier G, Cussenot O, Kraus
P, Just W, Paiss T, Cantu JM, Vogel W. (CAG)nCAA
and GGN repeats in the human androgen receptor
gene are not associated with prostate cancer in a
French-German population. Eur J Hum Genet. 1999;
7(3): 357-362.
32. Salinas CA, Austin MA, Ostrander EO, Stanford
JL. Polymorphisms in the androgen receptor and the
prostate-specifi c antigen genes and prostate cancer
risk. Prostate. 2005; 65(1): 58-65.
33. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics,
2010. CA Cancer J Clin. 2010; 60(5): 277-300.
34. Polednak AP. Trends in prostate carcinoma inci
dence in Connecticut (1988-1994) by age and race.
Cancer. 1997; 79(1): 99-103.
35. Rodriguez-Gonzalez G, Cabrera S, Ramirez-
Moreno R, Bilbao C, Diaz-Chico JC, Serra L, Chesa
N, Cabrera JJ, Diaz-Chico BN. Short alleles of both
GGN and CAG repeats at the exon-1 of the androgen
receptor gene are associated to increased PSA staining
and a higher Gleason score in human prostatic cancer.
J Steroid Biochem Mol Biol. 2009; 113(1-2): 85-91.
36. Platz EA, Giovannucci E, Dahl DM, Krithivas K,
Hennekens CH, Brown M, Stampfer MJ, Kantoff
PW. The androgen receptor gene GGN microsatellite
and prostate cancer risk. Cancer Epidemiol
Biomarkers Prev. 1998; 7(5): 379-384.
37. Platz EA, Leitzmann MF, Rifai N, Kantoff PW,
Chen YC, Stampfer MJ, Willett WC, Giovannucci E.
Sex steroid hormones and the androgen receptor gene
CAG repeat and subsequent risk of prostate cancer in
the prostate-specifi c antigen era. Cancer Epidemiol
Biomarkers Prev. 2005; 14(5): 1262-1269.
38. Bousema JT, Bussemakers MJ, van Houwelingen
KP, Debruyne FM, Verbeek AL, de La Rosette JJ,
Kiemeney LA. Polymorphisms in the vitamin D receptor
gene and the androgen receptor gene and the
risk of benign prostatic hyperplasia. Eur Urol. 2000;
37(2): 234-238.
39. Kristal AR, Price DK, Till C, Schenk JM, Neuhouser
ML, Ockers S, Lin DW, Thompson IM, Figg WD.
Androgen receptor CAG repeat length is not associated
with the risk of incident symptomatic benign prostatic
hyperplasia: results from the Prostate Cancer
Prevention Trial. Prostate. 2010; 70(6): 584-590.
40. Gsur A, Preyer M, Haidinger G, Zidek T,
Madersbacher S, Schatzl G, Marberger M, Vutuc C,
Micksche M. Polymorphic CAG repeats in the androgen
receptor gene, prostate-specifi c antigen polymorphism
and prostate cancer risk. Carcinogenesis.
2002; 23(10): 1647-1651.
|
|
|
|
 |
Number 27
VOL. 27 (2), 2024 |
Number 27
VOL. 27 (1), 2024 |
Number 26
Number 26 VOL. 26(2), 2023 All in one |
Number 26
VOL. 26(2), 2023 |
Number 26
VOL. 26, 2023 Supplement |
Number 26
VOL. 26(1), 2023 |
Number 25
VOL. 25(2), 2022 |
Number 25
VOL. 25 (1), 2022 |
Number 24
VOL. 24(2), 2021 |
Number 24
VOL. 24(1), 2021 |
Number 23
VOL. 23(2), 2020 |
Number 22
VOL. 22(2), 2019 |
Number 22
VOL. 22(1), 2019 |
Number 22
VOL. 22, 2019 Supplement |
Number 21
VOL. 21(2), 2018 |
Number 21
VOL. 21 (1), 2018 |
Number 21
VOL. 21, 2018 Supplement |
Number 20
VOL. 20 (2), 2017 |
Number 20
VOL. 20 (1), 2017 |
Number 19
VOL. 19 (2), 2016 |
Number 19
VOL. 19 (1), 2016 |
Number 18
VOL. 18 (2), 2015 |
Number 18
VOL. 18 (1), 2015 |
Number 17
VOL. 17 (2), 2014 |
Number 17
VOL. 17 (1), 2014 |
Number 16
VOL. 16 (2), 2013 |
Number 16
VOL. 16 (1), 2013 |
Number 15
VOL. 15 (2), 2012 |
Number 15
VOL. 15, 2012 Supplement |
Number 15
Vol. 15 (1), 2012 |
Number 14
14 - Vol. 14 (2), 2011 |
Number 14
The 9th Balkan Congress of Medical Genetics |
Number 14
14 - Vol. 14 (1), 2011 |
Number 13
Vol. 13 (2), 2010 |
Number 13
Vol.13 (1), 2010 |
Number 12
Vol.12 (2), 2009 |
Number 12
Vol.12 (1), 2009 |
Number 11
Vol.11 (2),2008 |
Number 11
Vol.11 (1),2008 |
Number 10
Vol.10 (2), 2007 |
Number 10
10 (1),2007 |
Number 9
1&2, 2006 |
Number 9
3&4, 2006 |
Number 8
1&2, 2005 |
Number 8
3&4, 2004 |
Number 7
1&2, 2004 |
Number 6
3&4, 2003 |
Number 6
1&2, 2003 |
Number 5
3&4, 2002 |
Number 5
1&2, 2002 |
Number 4
Vol.3 (4), 2000 |
Number 4
Vol.2 (4), 1999 |
Number 4
Vol.1 (4), 1998 |
Number 4
3&4, 2001 |
Number 4
1&2, 2001 |
Number 3
Vol.3 (3), 2000 |
Number 3
Vol.2 (3), 1999 |
Number 3
Vol.1 (3), 1998 |
Number 2
Vol.3(2), 2000 |
Number 2
Vol.1 (2), 1998 |
Number 2
Vol.2 (2), 1999 |
Number 1
Vol.3 (1), 2000 |
Number 1
Vol.2 (1), 1999 |
Number 1
Vol.1 (1), 1998 |
|
|
